MediciNova Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 8
Employees
  • Stock Symbol
  • MNOV
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $6.54
  • (As of Thursday Closing)

MediciNova General Information

Description

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 4275 Executive Square
  • Suite 650
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MediciNova Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.54 $6.72 $2.79 - $13.25 $290M 44.4M 1.6M -$0.25

MediciNova Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 177,518 232,622 279,728 209,036
Revenue 0 0 0 0
EBITDA (12,316) (14,053) (15,584) (13,025)
Net Income (11,527) (12,942) (14,675) (11,163)
Total Assets 75,838 79,205 77,223 43,419
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MediciNova Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MediciNova‘s full profile, request access.

Request a free trial

MediciNova Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore MediciNova‘s full profile, request access.

Request a free trial

MediciNova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of
Pharmaceuticals
San Diego, CA
8 As of 2019
00000
00000000000 00000

0000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
000000000000000
East Rutherford, NJ
0000 As of 0000
0.00 0000-00-00
000000000000

00000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. E
0000 000000000
Mumbai, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MediciNova Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ 0000 000000000000
00000 Corporation Mumbai, India 00000 00000000
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
000000 Formerly VC-backed Loos, France 000 00000 000000000. 0 00000
You’re viewing 5 of 21 competitors. Get the full list »

MediciNova Executive Team (11)

Name Title Board Seat Contact Info
Yuichi Iwaki MD Chief Executive Officer & President
Edward Stepanow Chief Financial Officer, Finance
Geoffrey O'Brien JD Vice President
Kazuko Matsuda Ph.D Chief Medical Officer & Board Member
You’re viewing 4 of 11 executive team members. Get the full list »

MediciNova Board Members (9)

Name Representing Role Since
David O'Toole Self Board Member 000 0000
Kazuko Matsuda Ph.D MediciNova Chief Medical Officer & Board Member 000 0000
Yutaka Kobayashi Self Board Member 000 0000
You’re viewing 3 of 9 board members. Get the full list »

MediciNova Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MediciNova Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 18-Dec-2009 000000000000000000 0000 Biotechnology 000000 00000 00
To view MediciNova’s complete acquisitions history, request access »